We are live on ! Find out more
PFO

Pathstone Family Office Portfolio holdings

AUM $13.1B
1-Year Est. Return 21.02%
This Fund
S&P 500
This Quarter Est. Return
+0.72%
1 Year Est. Return
+21.02%
3 Year Est. Return
+39.27%
5 Year Est. Return
+59.47%
10 Year Est. Return
+236.85%
AUM
$768M
AUM Growth
-$80.1M
Cap. Flow
-$27.1M
Cap. Flow %
-3.53%
Top 10 Hldgs %
60.99%
Holding
740
New
85
Increased
91
Reduced
143
Closed
103

Sector Composition

Rank Sector Weight
1 Financials 25.36%
2 Technology 10.73%
3 Consumer Discretionary 9.26%
4 Communication Services 3.87%
5 Industrials 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WORK
726
DELISTED
Slack Technologies, Inc.
WORK
-1,195
Closed -$45K
NTRP
727
DELISTED
Neurotrope, Inc. Common
NTRP
-12,694
Closed -$102K
PYX
728
DELISTED
Pyxus International, Inc.
PYX
$0 ﹤0.01%
54
TIVO
729
DELISTED
Tivo Inc
TIVO
$0 ﹤0.01%
49
QHC
730
DELISTED
Quorum Health Corporation
QHC
$0 ﹤0.01%
2
RTN
731
DELISTED
Raytheon Company
RTN
-3,375
Closed -$587K
CSS
732
DELISTED
CSS Industries, Inc.
CSS
$0 ﹤0.01%
47
APC
733
DELISTED
Anadarko Petroleum
APC
-2,346
Closed -$166K
LEXEA
734
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
-599
Closed -$29K
LLL
735
DELISTED
L3 Technologies, Inc.
LLL
-1,600
Closed -$393K
EMMS
736
DELISTED
Emmis Communications Corp
EMMS
$0 ﹤0.01%
1
ASCMA
737
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
-64
Closed
FTR
738
DELISTED
Frontier Communications Corp.
FTR
$0 ﹤0.01%
5
-75
-94% -$84
RHT
739
DELISTED
Red Hat Inc
RHT
-200
Closed -$38K
TCF
740
DELISTED
TCF Financial Corporation
TCF
-2,150
Closed -$45K

Similar funds

Pathstone Family Office's Q3 2019 Portfolio in Review

As of Q3 2019, Pathstone Family Office held 740 positions worth $768M, down 9.5% from $848M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Pathstone Family Office withdrew a net $27.1M in Q3 2019, closing 103 positions and reducing 143 holdings. Its most notable exit was UroGen Pharma, an estimated $1.47M position sold in full.

By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 25% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Pathstone Family Office opened a new position in Xylem worth $529K.

  • Pathstone Family Office's largest Q3 2019 buy was Xylem: 6,643 shares worth $529K.
  • Pathstone Family Office added most to Vanguard S&P 500 ETF in Q3 2019, an estimated $1.75M increase.
  • Pathstone Family Office's biggest Q3 2019 reduction was Royal Bank of Canada, cutting an estimated $11.3M.
  • Pathstone Family Office fully exited UroGen Pharma in Q3 2019, selling an estimated $1.47M.
  • Pathstone Family Office's ten largest holdings make up 61% of its $768M portfolio in Q3 2019.
  • Pathstone Family Office opened 85 new positions and closed 103 in Q3 2019.
  • Pathstone Family Office's portfolio value fell 9.5% quarter-over-quarter to $768M.

Based on Pathstone Family Office's 13F filing for Q3 2019, filed 13 Nov 2019.